Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Multilevel View of the Development of Alzheimer’s Disease
Jesús Ávila, George Perry
Neuroscience (2020) Vol. 457, pp. 283-293
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Western diet as a trigger of Alzheimer’s disease: From metabolic syndrome and systemic inflammation to neuroinflammation and neurodegeneration
Angelika Więckowska‐Gacek, Anna Mietelska‐Porowska, Małgorzata Wydrych, et al.
Ageing Research Reviews (2021) Vol. 70, pp. 101397-101397
Open Access | Times Cited: 235
Alzheimer’s Disease and Green Tea: Epigallocatechin-3-Gallate as a Modulator of Inflammation and Oxidative Stress
Víctor Valverde-Salazar, Daniel Ruiz-Gabarre, Vega García‐Escudero
Antioxidants (2023) Vol. 12, Iss. 7, pp. 1460-1460
Open Access | Times Cited: 30
Memory enhancement by transcranial radiofrequency wave treatment occurs without appreciably increasing brain temperature
Rob Baranowski, John Amschler, Dave Wittwer, et al.
Physical and Engineering Sciences in Medicine (2025)
Closed Access | Times Cited: 1
Dissecting the Crosstalk between Endothelial Mitochondrial Damage, Vascular Inflammation, and Neurodegeneration in Cerebral Amyloid Angiopathy and Alzheimer’s Disease
Rebecca Parodi‐Rullán, Sabzali Javadov, Silvia Fossati
Cells (2021) Vol. 10, Iss. 11, pp. 2903-2903
Open Access | Times Cited: 54
Metformin a Potential Pharmacological Strategy in Late Onset Alzheimer’s Disease Treatment
Saghar Rabiei Poor, Miren Ettcheto, Amanda Cano, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 9, pp. 890-890
Open Access | Times Cited: 33
Increased RyR2 open probability induces neuronal hyperactivity and memory loss with or without Alzheimer's disease–causing gene mutations
Jinjing Yao, Ya‐Jing Liu, Bo Sun, et al.
Alzheimer s & Dementia (2022) Vol. 18, Iss. 11, pp. 2088-2098
Closed Access | Times Cited: 25
Cortical cerebrovascular and metabolic perturbations in the 5xFAD mouse model of Alzheimer’s disease
Amandine Jullienne, Jenny I. Szu, Ryan Quan, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 15
Unlocking the Therapeutic Potential of Natural Products for Alzheimer’s Disease
Zhonghua Li, Zhenqiang Zhang, Bin Yu
Journal of Medicinal Chemistry (2025)
Closed Access
Kai-Xin-San ameliorates mild cognitive impairment in SAMP8 mice by inhibiting neuroinflammation and pyroptosis via NLRP3/Caspase-1 pathway modulation
Shu Liu, Xiaochen Song, Yuefeng Sun, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Targeting Necroptosis as a Promising Therapy for Alzheimer’s Disease
Wenli Zhao, Yue Liu, Lijuan Xu, et al.
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 12, pp. 1697-1713
Closed Access | Times Cited: 19
Research Progress on Mechanism of Neuroprotective Roles of Apelin-13 in Prevention and Treatment of Alzheimer’s Disease
Teng Wan, Mingyuan Fu, Yan Jiang, et al.
Neurochemical Research (2021) Vol. 47, Iss. 2, pp. 205-217
Open Access | Times Cited: 25
Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease
Yi Sun, Lijuan Xu, Hongming Shao, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 21, pp. 14957-14969
Closed Access | Times Cited: 17
Alzheimer's disease is an inherent, natural part of human brain aging: an integrated perspective.
Isidró Ferrer
DOAJ (DOAJ: Directory of Open Access Journals) (2022) Vol. 3
Closed Access | Times Cited: 16
Application of Sebum Lipidomics to Biomarkers Discovery in Neurodegenerative Diseases
Stefania Briganti, Mauro Truglio, Antonella Angiolillo, et al.
Metabolites (2021) Vol. 11, Iss. 12, pp. 819-819
Open Access | Times Cited: 21
Engineering of structural and functional properties of nanotherapeutics and nanodiagnostics for intranasal brain targeting in Alzheimer's
Nikita Hinge, Himanshu Kathuria, Murali Monohar Pandey
Applied Materials Today (2021) Vol. 26, pp. 101303-101303
Closed Access | Times Cited: 20
Progressive Vascular Abnormalities in the Aging 3xTg-AD Mouse Model of Alzheimer’s Disease
Amandine Jullienne, Ryan Quan, Jenny I. Szu, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1967-1967
Open Access | Times Cited: 15
A Survey on EEG Data Analysis Software
Rupak Kumar Das, Anna Lisa Martin‐Niedecken, Tom Zurales, et al.
Sci (2023) Vol. 5, Iss. 2, pp. 23-23
Open Access | Times Cited: 8
WWOX and Its Binding Proteins in Neurodegeneration
Che-Yu Hsu, Kuan‐Ting Lee, T.-C. Sun, et al.
Cells (2021) Vol. 10, Iss. 7, pp. 1781-1781
Open Access | Times Cited: 19
Early memory deficits and extensive brain network disorganization in the App/MAPT double knock-in mouse model of familial Alzheimer’s disease
Christopher Borcuk, Céline Héraud, Karine Herbeaux, et al.
Aging Brain (2022) Vol. 2, pp. 100042-100042
Open Access | Times Cited: 13
Identification of Cinnamein, a Component of Balsam of Tolu/Peru, as a New Ligand of PPARα for Plaque Reduction and Memory Protection in a Mouse Model of Alzheimer’s Disease
Mary McKay, Sukhamoy Gorai, Ramesh Kumar Paidi, et al.
Journal of Alzheimer s Disease Reports (2024) Vol. 8, Iss. 1, pp. 903-922
Open Access | Times Cited: 2
Complement 3a induces the synapse loss via C3aR in mitochondria-dependent NLRP3 activating mechanisms during the development and progression of Alzheimer’s disease
Tong-Qi Ge, Peipei Guan, Pu Wang
Neuroscience & Biobehavioral Reviews (2024) Vol. 165, pp. 105868-105868
Closed Access | Times Cited: 2
Ginkgolides and Huperzine A for complementary treatment of Alzheimer's disease
Cecilia Villegas, Rebeca Pérez, Lyvia Lintzmaier Petiz, et al.
IUBMB Life (2022) Vol. 74, Iss. 8, pp. 763-779
Closed Access | Times Cited: 11
Cerebrovascular microRNA Expression Profile During Early Development of Alzheimer’s Disease in a Mouse Model
Phoebe P. Chum, Md Abdul Hakim, Erik J. Behringer
Journal of Alzheimer s Disease (2021) Vol. 85, Iss. 1, pp. 91-113
Open Access | Times Cited: 14
Quality of Life and Relationships in Caregivers of People With Dementia. A Gender Perspective
Heidi Bjørge, Kari Kvaal, Ingun Ulstein
American Journal of Alzheimer s Disease & Other Dementias® (2024) Vol. 39
Open Access | Times Cited: 1
Specific Composite Biomarker Profiles for β-Amyloid Accumulation in Peripheral Blood in Healthy Subjects Relevant to Biological Factors: Comparison with Patients with Dementia
Kouji Satoh, Maremi Sato‐Ueshima, Hiroyo Kagami‐Katsuyama, et al.
Journal of Biotechnology and Biomedicine (2024) Vol. 07, Iss. 01
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top